RAPT Therapeutics Inc (NASDAQ:RAPT) has a beta value of -0.02 and has seen 0.46 million shares traded in the recent trading session. The company, currently valued at $174.45M, closed the recent trade at $10.55 per share which meant it gained $1.83 on the day or 20.99% during that session. The RAPT stock price is -190.05% off its 52-week high price of $30.60 and 46.26% above the 52-week low of $5.67. If we look at the company’s 10-day average daily trading volume, we find that it stood at 55680.0 shares traded. The 3-month trading volume is 109.48K shares.
The consensus among analysts is that RAPT Therapeutics Inc (RAPT) is Buy stock at the moment, with a recommendation rating of 2.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 6 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight.
RAPT Therapeutics Inc (NASDAQ:RAPT) trade information
Sporting 20.99% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the RAPT stock price touched $10.55 or saw a rise of 11.64%. Year-to-date, RAPT Therapeutics Inc shares have moved -62.10%, while the 5-day performance has seen it change 31.38%. Over the past 30 days, the shares of RAPT Therapeutics Inc (NASDAQ:RAPT) have changed 20.99%. Short interest in the company has seen 0.75 million shares shorted with days to cover at 6.54.
Wall Street analysts have a consensus price target for the stock at $33, which means that the shares’ value could jump 68.03% from the levels at last check today.. The projected low price target is $2.0 while the price target rests at a high of $55.0. In that case, then, we find that the latest price level in today’s session is -421.33% off the targeted high while a plunge would see the stock lose 81.04% from the levels at last check today..
RAPT Therapeutics Inc (RAPT) estimates and forecasts
The company’s shares have lost -0.09% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -10.10% over the past 5 years. Earnings growth for 2025 is a modest 89.06% while over the next 5 years, the company’s earnings are expected to increase by 53.09%.
RAPT Dividends
RAPT Therapeutics Inc is expected to release its next earnings report on 2025-May-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
RAPT Therapeutics Inc (NASDAQ:RAPT)’s Major holders
Insiders own 0.42% of the company shares, while shares held by institutions stand at 99.41% with a share float percentage of 99.83%. Investors are also buoyed by the number of investors in a company, with RAPT Therapeutics Inc having a total of 127.0 institutions that hold shares in the company. The top two institutional holders are FMR LLC with over 5.24 million shares worth more than $15.97 million. As of 2024-06-30, FMR LLC held 13.4704% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 3.11 million shares as of 2024-06-30. The firm’s total holdings are worth over $9.48 million and represent 7.9972% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.52% shares in the company for having 689.13 shares of worth $7.02 million while later fund manager owns 180.05 shares of worth $1.83 million as of Mar 31, 2025 , which makes it owner of about 0.14% of company’s outstanding stock.
